Virpax Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.967; its P/E ratio is -0.28; Virpax Pharmaceuticals is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -3.11M	$ -1.52M	$ -2.99M	$ -7.64M	$ -5.88M
EBITDA	$ -3.11M	$ -1.52M	$ -2.99M	$ -7.64M	$ -5.88M
Net Income Common Stockholders	$ -3.11M	$ 1.78M	$ -2.99M	$ -7.64M	$ -5.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 16.99M	$ 19.00M	$ 20.56M	$ 26.06M
Total Assets	$ 15.95M	$ 18.49M	$ 19.67M	$ 23.64M	$ 29.40M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ 0.00	$ -16.99M	$ -19.00M	$ -20.56M	$ -26.06M
Total Liabilities	$ 3.65M	$ 3.29M	$ 3.09M	$ 4.21M	$ 2.48M
Stockholders Equity	$ 12.30M	$ 15.20M	$ 16.58M	$ 19.43M	$ 26.92M
Cash Flow	-
Free Cash Flow	$ -2.18M	$ -2.01M	$ -1.57M	$ -5.50M	$ -4.74M
Operating Cash Flow	$ -2.18M	$ -2.01M	$ -1.57M	$ -5.50M	$ -4.74M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	$ 0.00	$ 0.00

Currency in USD

Virpax Pharmaceuticals Earnings and Revenue History

Income Statement >

Virpax Pharmaceuticals Debt to Assets

Balance Sheet >

Virpax Pharmaceuticals Cash Flow

Cash Flow >

Virpax Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing